Matrix Metalloproteinases in Human Melanoma
Top Cited Papers
- 1 September 2000
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 115 (3), 337-344
- https://doi.org/10.1046/j.1523-1747.2000.00068.x
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disordersClinical and Experimental Dermatology, 1999
- Cell surface binding and activation of gelatinase A induced by expression of membrane‐type‐1‐matrix metalloproteinase (MT1‐MMP)FEBS Letters, 1996
- The incidence of malignant melanoma in the United States: Issues as we approach the 21st centuryJournal of the American Academy of Dermatology, 1996
- TIMP-2 Growth-Stimulatory Activity: A Concentration- and Cell Type-Specific Response in the Presence of InsulinExperimental Cell Research, 1996
- The plasminogen activation system in melanoma cell lines and in melanocytic lesionsMelanoma Research, 1996
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- Expression of Stromelysin 3 in the Stromal Elements of Human Basal Cell CarcinomaDiagnostic Molecular Pathology, 1992
- Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serumFEBS Letters, 1992
- Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990